Skip to main content
Fig. 1 | Advances in Rheumatology

Fig. 1

From: The impact of normal serum complement levels on the disease classification and clinical characteristics in systemic lupus erythematosus

Fig. 1

Study design for enrolling patients. Of patients who fulfilled the American College of Rheumatology (ACR) 1997 or the Systemic Lupus International Collaborating Clinics (SLICC) 2012 criteria at the initial diagnosis, patients with normal serum levels of C3, C4, and CH50 (N-com) and those with lower than normal serum levels of one or more complements in C3, C4, and/or CH50 (H-com) were classified. Others: patients who were insufficient for determining N-com or H-com, those who had infection or malignancy, or those whose clinical information was insufficient for the analyses

Back to article page

Advances in Rheumatology

ISSN: 2523-3106